Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 13.10.2025 1 Ann Neurol 2 Arch Phys Med Rehabil 1 Brain 1 J Neurol 2 Lancet 5 Mult Scler 1 Nat Rev Neurol 2 Neurologia (Engl Ed) 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. SIMPSON-YAP S, Morwitch E, Tanner SA, Thomson SM, et al
   Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset.
   Ann Neurol. 2025 Oct 10. doi: 10.1002/ana.78043.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. MOTL RW, Silic P, Huynh TLT, Jeng B, et al
   Validity of Scores from the 12-Item Multiple Sclerosis Walking Scale Among Young, Middle-Aged, and Older Adults with Multiple Sclerosis.
   Arch Phys Med Rehabil. 2025 Oct 7:S0003-9993(25)00941.
   PubMed         Abstract available
   
   
3. DELMASTRO HM, Turner AP, Gomes KE, Neto LO, et al
   The relationship between physical activity domains by level and illness intrusiveness in people with multiple sclerosis.
   Arch Phys Med Rehabil. 2025 Oct 2:S0003-9993(25)00932.
   PubMed         Abstract available
   
   

   
   Brain

4. MUKHERJEE T, McMurran CE, Holland J, Daruwalla C, et al
   Ageing and remyelination failure in people with multiple sclerosis.
   Brain. 2025 Oct 6:awaf373. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neurol

5. AHMAD R, Jackson-Tarlton CS, Flanagan EP, Messina S, et al
   Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.
   J Neurol. 2025;272:677.
   PubMed         Abstract available
   
   

   
   Lancet

6. FILIPPI M, Rocca MA
   MS-STAT2: lessons from negative trials in multiple sclerosis.
   Lancet. 2025 Oct 1:S0140-6736(25)01673-3. doi: 10.1016/S0140-6736(25)01673.
   PubMed        
   
   
7. CHATAWAY J, Williams T, Blackstone J, John N, et al
   Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
   Lancet. 2025 Oct 1:S0140-6736(25)01039-6. doi: 10.1016/S0140-6736(25)01039.
   PubMed         Abstract available
   
   

   
   Mult Scler

8. SUTHIPHOSUWAN S, Lim TR, Hu Z, Colak E, et al
   Choroid plexus enlargement correlates with demyelinating lesions and thalamic atrophy in radiologically isolated syndrome.
   Mult Scler. 2025;31:1314-1325.
   PubMed         Abstract available
   
   
9. AJDINAJ P, Mongay-Ochoa N, Alberich M, Tintore M, et al
   Long-term impact of spinal cord reserve on disability accumulation in multiple sclerosis.
   Mult Scler. 2025 Oct 7:13524585251378995. doi: 10.1177/13524585251378995.
   PubMed         Abstract available
   
   
10. BALSHI A, Feldman TB, Dempsey JP, Baber U, et al
    A multicenter cohort of transgender and gender diverse people with multiple sclerosis.
    Mult Scler. 2025 Oct 8:13524585251383330. doi: 10.1177/13524585251383330.
    PubMed         Abstract available
    
    
11. BARBUTI E, Prosperini L, Ruggieri S, Haggiag S, et al
    How premorbid structural reserve affects disability accrual in multiple sclerosis.
    Mult Scler. 2025 Oct 8:13524585251372440. doi: 10.1177/13524585251372440.
    PubMed         Abstract available
    
    
12. BORDET C, Maachi O, Papeix AC, Laigo P, et al
    Human papillomavirus-related conditions in women with multiple sclerosis receiving disease-modifying therapies: A Pharmacovigilance disproportionality analysis from the WHO vigibase(R).
    Mult Scler. 2025 Oct 8:13524585251377411. doi: 10.1177/13524585251377411.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

13. KIANI L
    Real-world effectiveness of stem cell transplantation for multiple sclerosis.
    Nat Rev Neurol. 2025 Oct 7. doi: 10.1038/s41582-025-01157.
    PubMed        
    
    

    
    Neurologia (Engl Ed)

14. ARRIAGADA OPAZO J, Farah Gonzalez V, Gonzalez Delgadillo M, Nunez-Franz L, et al
    Multiple Sclerosis mortality trend by sex: Chile 1997-2019.
    Neurologia (Engl Ed). 2025 Oct 6:S2173-5808(25)00098.
    PubMed         Abstract available
    
    
15. PINAR MORALES R, Guirado Ruiz PA, Barrero Hernandez FJ
    Impact of fatigue on quality of life in adults with relapsing-remitting multiple sclerosis.
    Neurologia (Engl Ed). 2025 Oct 7:S2173-5808(25)00101.
    PubMed         Abstract available
    
    

    
    PLoS One

16. AL-EITAN L, Ataa A
    Investigating genetic links of vitamin D metabolism pathway genes (CYP2R1, CYP27B1, CYP24A1, and DBP) in Multiple Sclerosis patients.
    PLoS One. 2025;20:e0333924.
    PubMed         Abstract available
    
    
17. SOLARI A, De Panfilis L, Zagarella RM, Ghirotto L, et al
    Advance care planning in multiple sclerosis (ConCure-SM): A multicenter single-arm pilot and feasibility study.
    PLoS One. 2025;20:e0331220.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.